ACM
WST icon

Anfield Capital Management’s West Pharmaceutical WST Stock Holding History

Anfield Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11
Closed -$5K – 132
2021
Q3 		$5K Buy
+11
New +$4.64K ﹤0.01% 97

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Anfield Capital Management's WST Position: Q4 2021 in Review

Anfield Capital Management sold out of West Pharmaceutical (WST) in Q4 2021, closing a stake of 11 shares — an estimated $5K sold.

Anfield Capital Management first reported a position in WST in Q3 2021 and held it in 1 quarter. The position peaked at $5K in Q3 2021. 730 funds tracked by Wall St. Rank hold WST as of Q4 2021.

  • Anfield Capital Management reported no remaining West Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • Anfield Capital Management sold 11 West Pharmaceutical shares in Q4 2021, an estimated $5K.
  • Anfield Capital Management first reported a position in West Pharmaceutical in Q3 2021 and held it in 1 quarter.
  • Anfield Capital Management's West Pharmaceutical position peaked at $5K in Q3 2021.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2021.

Based on Anfield Capital Management's 13F filing for Q4 2021, filed 3 Feb 2022.